Neuromodulation cryotherapeutic devices and associated systems and methods

Inventors: Naomi Buckley (Galway, IE); Benjamin J. Clark (Redwood City, CA); Michael Cummins (Roscam, IE); Danny Donovan (Galway, IE); Mark Gelfand (New York, NY); Luke Hughes (Galway, IE); Brian Kelly (Galway, IE); Gary Kelly (Windsor, CA); Grace Kelly (Clifden, IE); John Kelly (Ballinsloe, IE); Mark S. Leung (Shawnigan Lake, CA); Gwenda Francis (Ballybrit, IE); Barry Mullins (Co. Wicklow, IE); Karun D. Naga (Los Altos, CA); Stephen Nash (Galway, IE); Eric Ryba (Durango, CO); Fiachra Sweeney (Galway, IE); Vincenzo Tilotta (Galway, IE); Roman Turovskiy (San Francisco, CA); Lana Woolley (Galway, IE); Denise Zarins (Saratoga, CA); Michael Turovskiy (East Palo Alto, CA)

Assignee: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.

A61B18/02 A61B2017/22054 A61B2017/22067 A61B2018/0022 A61B2018/00023 A61B2018/0025 A61B2018/00166 A61B2018/00232 A61B2018/00261 A61B2018/00404 A61B2018/00434 A61B2018/00511 A61B2018/00577 A61B2018/0212 A61B2018/0262

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 10,842,547
App. No.: 16/221,174
Granted: Nov 24, 2020
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

Neuromodulation cryotherapeutic devices and associated systems and methods are disclosed herein. A cryotherapeutic device configured in accordance with a particular embodiment of the present technology can include an elongated shaft having distal portion and a supply lumen along at least a portion of the shaft. The shaft can be configured to locate the distal portion intravascularly at a treatment site proximate a renal artery or renal ostium. The supply lumen can be configured to receive a liquid refrigerant. The cryotherapeutic device can further include a cooling assembly at the distal portion of the shaft. The cooling assembly can include an applicator in fluid communication with the supply lumen and configured to deliver cryotherapeutic cooling to nerves proximate the target site when the cooling assembly is in a deployed state.

Claims (36)

1. A cryotherapeutic device, comprising;

an elongate shaft having a distal end portion, wherein the elongate shaft is configured to locate the distal end portion intravascularly at a treatment site within a renal artery or renal ostium;

an exhaust passage extending along a length of the elongate shaft, wherein the exhaust passage is configured to carry gaseous refrigerant proximally along the length of the shaft;

a supply lumen extending along the length of the elongate shaft, wherein the supply lumen is configured to carry liquid refrigerant distally along the length of the elongate shaft, and wherein the supply lumen includes—

a helical portion that wraps around the exhaust passage at the distal end portion of the elongate shaft, and

an orifice at the helical portion; and

a cooling assembly at the distal end portion of the elongate shaft, wherein the cooling assembly has a low-profile delivery state and an expanded deployed state, and wherein the cooling assembly includes an applicator having a balloon with a wall, and wherein the applicator further comprises—

a first heat-transfer portion configured to have a first heat-transfer rate while the cooling assembly is in the expanded deployed state and while the cooling assembly receives refrigerant via the supply lumen, wherein the orifice is configured to direct refrigerant from the supply lumen toward the first heat-transfer portion; and

a second heat-transfer portion configured to have a second heat-transfer rate while the cooling assembly is in the expanded deployed state and while the cooling assembly receives refrigerant via the supply lumen, wherein the second heat-transfer rate is less than the first heat-transfer rate,

wherein the first heat-transfer portion and second heat-transfer portion are helical, and wherein the portions of the wall of the balloon between the first heat transfer portion and the second heat-transfer portion are thermally insulated.

2. The cryotherapeutic device of claim 1 wherein the balloon comprises:

a first wall portion having a first average thickness; and

a second wall portion having a second average thickness, wherein the second average thickness is greater than the first average thickness.

3. The cryotherapeutic device of claim 1 , further comprising an occlusion member spaced apart proximally from the applicator, wherein the occlusion member has a low-profile collapsed state and an expanded deployed state, and wherein the occlusion member is configured to fully occlude the renal artery or renal ostium proximal of the treatment site when the occlusion member is in the expanded deployed state.

4. The cryotherapeutic device of claim 3 , further comprising a filler lumen extending along the length of the elongate shaft, wherein the filler lumen is fluidly connected to the occlusion member, and wherein the occlusion member is fluidly separate from the supply lumen.

5. The cryotherapeutic device of claim 1 wherein the supply lumen comprises a plurality of orifices extending along the helical portion, and wherein: